Edward Kim

发表

NCCN Soft Tissue Sarcoma , Version 2 . 2016 Clinical Practice Guidelines in Oncology

M. McCarter, M. Heslin, R. Gonzalez, 2016 .

Intraoperative radiotherapy in the multimodality approach to bone and soft tissue cancers.

B. Eisenberg, T. Kinsella, R. Ellis, 2003, Surgical oncology clinics of North America.

Hematologic outcomes of myelodysplastic syndromes treatment with hypomethylating agents in community practice.

B. Feinberg, E. Farrelly, R. Bordoni, 2011, Clinical lymphoma, myeloma & leukemia.

Use of hypomethylating agents and associated care in patients with myelodysplastic syndromes: a claims database study

Swu-Jane Lin, H. Hatoum, Edward Kim, 2011, Current medical research and opinion.

Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

M. McCarter, M. Heslin, R. Gonzalez, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cells

J. Heymach, L. Byers, C. Pickering, 2014, Head & neck.

Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

J. Sicklick, M. Bui, R. Riedel, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

Economic analysis of decitabine versus best supportive care in the treatment of intermediate- and high-risk myelodysplastic syndromes from a US payer perspective.

K. Knopf, R. Fleurence, J. Linnehan, 2010, Clinical therapeutics.

Primary cutaneous Epstein-Barr virus-positive diffuse large B-cell lymphoma (DLBCL) in a patient taking fingolimod.

R. S. Hopkins, G. Fan, C. Okada, 2019, Dermatology online journal.

NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021.

J. Sicklick, S. Dry, M. McCarter, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

Management of rash and other toxicities in patients treated with epidermal growth factor receptor-targeted agents.

Edward Kim, J. Rhee, K. Oishi, 2005, Clinical colorectal cancer.

Cytomegalovirus viremia and resistance patterns in immunocompromised children: An 11-year experience

B. Asmar, Ronald Thomas, N. Abdel-Haq, 2019, Pediatric hematology and oncology.

Treatment of Acute Graft-versus-Host Disease in Liver Transplant Recipients

J. S. Daly, Shinya U. Amano, A. Bozorgzadeh, 2021, Case reports in transplantation.

Validation of a Molecular and Pathological Model for Five-Year Mortality Risk in Patients with Early Stage Lung Adenocarcinoma

I. Wistuba, R. Bueno, A. Gutin, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Optimizing chemotherapy and targeted agent combinations in NSCLC.

Edward Kim, T. Lynch, 2005, Lung cancer.

A prospective randomized, controlled trial of eculizumab to prevent ischemia‐reperfusion injury in pediatric kidney transplantation

O. Dymova, R. Shapiro, N. Babenko, 2018, Pediatric transplantation.

Gastrointestinal Malignancies

S. Russo, Edward Kim, Sarah E, 2018, Practical Guides in Radiation Oncology.

Brachytherapy: Update and results

R. Ellis, Edward Kim, 2003, Current urology reports.

Explorer Validation of a molecular and pathological model for five-year mortality risk in patients with early stage lung adenocarcinoma

I. Wistuba, R. Bueno, A. Gutin, 2017 .

Combination TACE and SBRT for Unresectable Single Large HCC: Results from a Prospective Phase II Trial.

K. Rosenzweig, J. Llovet, M. Schwartz, 2022, International journal of radiation oncology, biology, physics.

Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinoma.

M. Resnick, T. Kinsella, P. Fu, 2003, International journal of radiation oncology, biology, physics.

External Beam Radiotherapy in Prostate Cancer

G. Camporeale, Edward Kim, I. Aral, 2013 .

Patterns of Hypomethylating Agent and Transfusion Use in Myelodysplastic Syndrome: a Claims Database Study.

Swu-Jane Lin, H. Hatoum, Edward Kim, 2009 .

NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022.

J. Sicklick, M. Bui, R. Riedel, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

Molecular pathogenesis of lung cancer with translation to the clinic: M10-01

K. Coombes, S. Lam, J. Minna, 2007 .

Hematologic outcomes of MDS treatment with hypomethylating agents in community practice.

J. Jackson, B. Feinberg, E. Farrelly, 2010 .

Intraperitoneal vancomycin treatment of multifocal methicillin-resistant Staphylococcus aureus osteomyelitis in a patient on peritoneal dialysis.

B. Asmar, R. Valentini, Edward Kim, 2020, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Role of ProstaScint® for brachytherapy in localized prostate adenocarcinoma

Ryan M. Foor, Rodney J Ellis, R. Ellis, 2004, Expert review of molecular diagnostics.

Gastrointestinal Malignancies

S. Russo, Edward Kim, Sarah E, 2018, Practical Guides in Radiation Oncology.